Literature DB >> 25964982

Profilin 2 promotes migration, invasion, and stemness of HT29 human colorectal cancer stem cells.

Min-Jung Kim1, Yoo-Sun Lee, Gi-Yeon Han, Han-Na Lee, Chiyoung Ahn, Chan-Wha Kim.   

Abstract

We investigated the role of profilin 2 in the stemness, migration, and invasion of HT29 cancer stem cells (CSCs). Increased and decreased levels of profilin 2 significantly enhanced and suppressed the self-renewal, migration, and invasion ability of HT29 CSCs, respectively. Moreover, profilin 2 directly regulated the expression of stemness markers (CD133, SOX2, and β-catenin) and epithelial mesenchymal transition (EMT) markers (E-cadherin and snail). CD133 and β-catenin were up-regulated by overexpression of profilin 2 and down-regulated by depletion of profilin 2. SOX2 was decreased by profilin 2 depletion. E-cadherin was not influenced by profilin 2- overexpression but increased by profilin 2- knockdown. The expression of snail was suppressed by profilin 2- knockdown. We speculated that stemness and the EMT are closely linked through profilin 2-related pathways. Therefore, this study indicates that profilin 2 affects the metastatic potential and stemness of colorectal CSCs by regulating EMT- and stemness-related proteins.

Entities:  

Keywords:  Cancer stem cells (CSCs); Invasion; Migration; Profilin 2; Stemness

Mesh:

Substances:

Year:  2015        PMID: 25964982     DOI: 10.1080/09168451.2015.1043118

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  14 in total

1.  A balanced level of profilin-1 promotes stemness and tumor-initiating potential of breast cancer cells.

Authors:  Chang Jiang; Zhijie Ding; Marion Joy; Souvik Chakraborty; Su Hyeong Kim; Ralph Bottcher; John Condeelis; Shivendra Singh; Partha Roy
Journal:  Cell Cycle       Date:  2017       Impact factor: 4.534

2.  Profilin choreographs actin and microtubules in cells and cancer.

Authors:  Morgan L Pimm; Jessica Hotaling; Jessica L Henty-Ridilla
Journal:  Int Rev Cell Mol Biol       Date:  2020-07-16       Impact factor: 6.813

3.  Oral Soft Tissue Regeneration Using Nano Controlled System Inducing Sequential Release of Trichloroacetic Acid and Epidermal Growth Factor.

Authors:  Kwang Man Park; Hong Jae Lee; Ki-Tae Koo; Heithem Ben Amara; Richard Leesungbok; Kwantae Noh; Sang Cheon Lee; Suk Won Lee
Journal:  Tissue Eng Regen Med       Date:  2020-01-22       Impact factor: 4.169

4.  Profilin 2 and Endothelial Exosomal Profilin 2 Promote Angiogenesis and Myocardial Infarction Repair in Mice.

Authors:  Zhenkun Li; Xueyun Huo; Keyan Chen; Fenghua Yang; Weijiang Tan; Qi Zhang; Haixu Yu; Changlong Li; Deshan Zhou; Hao Chen; Baoquan Zhao; Yuan Wang; Zhenwen Chen; Xiaoyan Du
Journal:  Front Cardiovasc Med       Date:  2022-04-11

5.  Analysis of different components in the peritumoral tissue microenvironment of colorectal cancer: A potential prospect in tumorigenesis.

Authors:  Chao Huang; Hong Liu; Xiuli Gong; Bin Wen; Dan Chen; Jinyuan Liu; Fengliang Hu
Journal:  Mol Med Rep       Date:  2016-08-01       Impact factor: 2.952

6.  Cell surface Thomsen-Friedenreich proteome profiling of metastatic prostate cancer cells reveals potential link with cancer stem cell-like phenotype.

Authors:  Feng Li; Olga V Glinskii; Brian P Mooney; Kate Rittenhouse-Olson; Kenneth J Pienta; Vladislav V Glinsky
Journal:  Oncotarget       Date:  2017-10-20

7.  Mesenchymal stem cells enhance tumorigenic properties of human glioblastoma through independent cell-cell communication mechanisms.

Authors:  Carolina Oliveira Rodini; Patrícia Benites Gonçalves da Silva; Amanda Faria Assoni; Valdemir Melechco Carvalho; Oswaldo Keith Okamoto
Journal:  Oncotarget       Date:  2018-05-15

8.  PFN2a Suppresses C2C12 Myogenic Development by Inhibiting Proliferation and Promoting Apoptosis via the p53 Pathway.

Authors:  Huaqin Li; Lianjie Hou; Yu Zhang; Fangyi Jiang; Yifan Zhu; Qing X Li; Ching Yuan Hu; Chong Wang
Journal:  Cells       Date:  2019-08-23       Impact factor: 6.600

9.  PTK7 promotes the malignant properties of cancer stem-like cells in esophageal squamous cell lines.

Authors:  Jun Bie; Xin Hu; Mi Yang; Xianwei Shi; Xinping Zhang; Ziwei Wang
Journal:  Hum Cell       Date:  2020-01-01       Impact factor: 4.374

10.  PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.

Authors:  Xiao-Bin Cui; Shu-Mao Zhang; Yue-Xun Xu; Hong-Wei Dang; Chun-Xia Liu; Liang-Hai Wang; Lan Yang; Jian-Ming Hu; Wei-Hua Liang; Jin-Fang Jiang; Na Li; Yong Li; Yun-Zhao Chen; Feng Li
Journal:  J Transl Med       Date:  2016-05-17       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.